Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

VistaGen Therapeutics, Inc. (VSTA)

Total paid for Promotions this month: $240,000
E-mails this Month: 2
Estimated Volume Generated: $0
Research Report on VSTA: Click to see
* The information presented is based on information for Dec , 2014
  VistaGen Therapeutics, Inc. (VSTA) VistaGen is a clinical-stage biopharmaceutical company developing innovative medicine for depression and diseases and conditions involving the central nervous system (CNS). VistaGen's AV-101 is a new generation orally-available NMDA receptor glycine B-site antagonist entering Phase 2 clinical development for Major Depressive Disorder. VistaGen is also leveraging its proprietary pluripotent stem ...read more
Promoter: Tip.us Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
VSTA $240,000
15,250 restricted trading shares
UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
  VistaGen Therapeutics, Inc. (VSTA) VistaGen is a clinical-stage biopharmaceutical company developing innovative medicine for depression, cancer and diseases and conditions involving the central nervous system. VistaGen's lead drug candidate, AV-101, is a novel, potent, oral NMDAR glycineB-site antagonist entering Phase 2 clinical development focused on depression. View The Full Company Profile Read Featured AV-101 Article VSTA: MissionIR received ...read more
Promoter: Tip.us Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
VSTA $240,000
15,250 restricted trading shares
UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
    The MissionIR Report - Mid-April 2013 In-depth analysis, timely updates, latest market news     Latest Edition Take a closer look at the companies that caught our attention this week as well as top market news. Newsletter.MissionIR.com   Stay Informed During the week we post regular articles on our blog, featuring the latest small-cap information. Blog.MissionIR.com       Ones ...read more
Promoter: MissionIR Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
VSTA $240,000
305,000 restricted trading shares
25,000 3-year warrants to purchase shares of VSTA Common Stock
UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
Blog    Video    Market Basics    Quotes & News    Clients    Partners    About Us     Contact Us The latest from QualityStocks - The QualityStocks Weekly Our Pick of the Week VistaGen Therapeutics, Inc. (VSTA) Weekly.QualityStocks.net The QualityStocks Weekly Newsletter ...read more
Promoter: QualityStocks Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
VSTA No compensation UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
Blog    Video    Market Basics    Quotes & News    Clients    Partners    About Us     Contact Us The latest from QualityStocks - The QualityStocks Weekly Our Pick of the Week VistaGen Therapeutics, Inc. (VSTA) Weekly.QualityStocks.net The QualityStocks Weekly Newsletter ...read more
Promoter: QualityStocks Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
VSTA No compensation UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
Video not found or You must install the Flash Plugin for your Browser in order to view this movie